2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 139 filers reported holding 2SEVENTY BIO INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $146,707 | -95.6% | 14,383 | -93.7% | 0.01% | -95.0% |
Q3 2022 | $3,321,000 | -64.0% | 228,245 | -67.4% | 0.16% | -65.3% |
Q2 2022 | $9,229,000 | +270.6% | 699,136 | +379.0% | 0.46% | +352.0% |
Q1 2022 | $2,490,000 | -51.9% | 145,965 | -27.8% | 0.10% | -19.0% |
Q4 2021 | $5,180,000 | – | 202,118 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 819,672 | $10,820,000 | 4.13% |
Madison Avenue Partners, LP | 1,511,300 | $19,949,000 | 4.08% |
Newtyn Management, LLC | 1,346,796 | $17,778,000 | 3.37% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $18,597,000 | 2.18% |
EcoR1 Capital, LLC | 3,495,943 | $46,146,000 | 1.59% |
Casdin Capital, LLC | 614,754 | $8,115,000 | 0.69% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $3,960,000 | 0.60% |
Birchview Capital, LP | 59,833 | $790,000 | 0.58% |
CAAS CAPITAL MANAGEMENT LP | 699,136 | $9,229,000 | 0.46% |
Altium Capital Management LP | 83,000 | $1,096,000 | 0.44% |